MGTA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 15.18%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Magenta Therapeutics Insider Trading History Chart

Magenta Therapeutics Share Price & Price History

^$0.70

▼ -0.0587 (-7.74%)

As of 09/11/2023 05:00 PM ET

Magenta Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/7/2023	Rock Ventures Iv L.P. Third	Major Shareholder	Sell	4,400,000	$0.42	$1,826,000.00	9,116,408

SEC Filings (Institutional Ownership Changes) for Magenta Therapeutics (NASDAQ:MGTA)

47.53% of Magenta Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Magenta Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2023	Corsair Capital Management L.P.	100,000	$76K	0.0%	+204.5%	0.165%
8/7/2023	Acadian Asset Management LLC	457,690	$0.35M	0.0%	-25.5%	0.754%
7/11/2023	Harbor Capital Advisors Inc.	167,454	$0.13M	0.0%	+10.1%	0.276%
5/16/2023	Atlas Venture Life Science Advisors LLC	3,791,698	$3.01M	0.4%	+9.1%	6.252%
5/12/2023	Corsair Capital Management L.P.	32,846	$26K	0.0%	N/A	0.054%
5/11/2023	Acadian Asset Management LLC	614,213	$0.49M	0.0%	+408.5%	1.013%
2/8/2023	Thrivent Financial for Lutherans	129,395	$47K	0.0%	N/A	0.214%
1/20/2023	Hellman Jordan Management Co. Inc. MA	441,125	$0.17M	0.3%	+142.4%	0.728%
11/16/2022	Alphabet Inc.	3,339,138	$4.71M	0.2%	N/A	5.514%
11/14/2022	RA Capital Management L.P.	3,588,081	$5.06M	0.1%	N/A	5.925%
11/14/2022	Ergoteles LLC	115,122	$0.16M	0.0%	-12.3%	0.190%
11/14/2022	Integral Health Asset Management LLC	377,000	$0.53M	0.1%	+14.8%	0.623%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	86,631	$0.12M	0.0%	+160.8%	0.143%
10/13/2022	Hellman Jordan Management Co. Inc. MA	181,964	$0.26M	0.4%	-38.3%	0.309%
9/27/2022	Hellman Jordan Management Co. Inc. MA	295,000	$0.35M	0.5%	N/A	0.501%
9/16/2022	Federated Hermes Inc.	189,312	$0.23M	0.0%	-51.1%	0.321%
8/16/2022	Woodline Partners LP	933,181	$1.12M	0.0%	+17.2%	1.585%
8/16/2022	Casdin Capital LLC	2,415,000	$2.90M	0.2%	-12.9%	4.101%
8/15/2022	Laurion Capital Management LP	582,300	$0.70M	0.0%	N/A	0.989%
8/13/2022	Virtu Financial LLC	77,069	$92K	0.0%	N/A	0.131%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	33,220	$40K	0.0%	N/A	0.056%
8/3/2022	Integral Health Asset Management LLC	328,269	$0.39M	0.1%	+63.3%	0.558%
7/26/2022	Harbor Capital Advisors Inc.	159,307	$0.19M	0.1%	+5.1%	0.271%
5/17/2022	Gilder Gagnon Howe & Co. LLC	3,383,850	$9.81M	0.1%	-7.9%	5.755%
5/16/2022	Deep Track Capital LP	5,359,000	$15.54M	1.0%	+10.0%	9.114%
5/12/2022	Integral Health Asset Management LLC	201,000	$0.58M	0.2%	+123.3%	0.342%
5/11/2022	GSA Capital Partners LLP	42,662	$0.12M	0.0%	+48.5%	0.073%
5/10/2022	Cheyne Capital Management UK LLP	47,170	$0.14M	0.1%	N/A	0.080%
4/28/2022	Harbor Capital Advisors Inc.	151,599	$0.44M	0.2%	-16.6%	0.258%
2/18/2022	TCG Crossover Management LLC	2,222,222	$9.84M	4.6%	N/A	3.781%
2/14/2022	Deep Track Capital LP	4,870,000	$21.57M	1.5%	N/A	8.286%
2/14/2022	GSA Capital Partners LLP	28,729	$0.13M	0.0%	N/A	0.049%
2/10/2022	Bleichroeder LP	484,400	$2.15M	0.3%	+11.5%	0.824%
2/10/2022	Acadian Asset Management LLC	6,637	$29K	0.0%	N/A	0.011%
2/9/2022	Principal Financial Group Inc.	596,678	$2.64M	0.0%	+23.7%	1.015%
2/9/2022	Alps Advisors Inc.	68,023	$0.30M	0.0%	-5.2%	0.116%
2/8/2022	First Trust Advisors LP	60,068	$0.27M	0.0%	+14.5%	0.102%
2/8/2022	Northern Trust Corp	309,276	$1.37M	0.0%	+2.3%	0.526%
2/4/2022	Harbor Capital Advisors Inc.	181,729	$0.81M	0.3%	N/A	0.309%
1/31/2022	Dupont Capital Management Corp	27,546	$0.12M	0.0%	-28.5%	0.047%
1/18/2022	Aries Wealth Management	42,000	$0.19M	0.0%	+133.3%	0.071%
12/14/2021	UBS Asset Management Americas Inc.	511,542	$3.72M	0.0%	-2.2%	0.870%
11/16/2021	Janus Henderson Group PLC	596,402	$4.34M	0.0%	+420.2%	1.015%
11/16/2021	Two Sigma Advisers LP	219,000	$1.59M	0.0%	+6.1%	0.373%
11/16/2021	Two Sigma Investments LP	142,365	$1.04M	0.0%	-16.8%	0.242%
11/16/2021	Casdin Capital LLC	3,901,589	$28.40M	0.7%	+16.6%	6.638%
11/15/2021	Great Point Partners LLC	1,170,000	$8.52M	2.0%	+5.3%	1.991%
11/15/2021	Eversept Partners LP	198,879	$1.45M	0.1%	N/A	0.338%
11/15/2021	Dimensional Fund Advisors LP	191,640	$1.40M	0.0%	-37.6%	0.326%
11/15/2021	Hershey Trust Co.	20,290	$0.15M	0.0%	N/A	0.035%
11/12/2021	Rockefeller Capital Management L.P.	3,600	$26K	0.0%	N/A	0.006%
11/12/2021	Credit Suisse AG	156,375	$1.14M	0.0%	+273.9%	0.266%
11/12/2021	Geode Capital Management LLC	528,274	$3.85M	0.0%	+5.0%	0.899%
11/12/2021	Integral Health Asset Management LLC	90,000	$0.66M	0.2%	+20.0%	0.153%
11/10/2021	Goldman Sachs Group Inc.	171,871	$1.25M	0.0%	+12.2%	0.293%
11/10/2021	Citigroup Inc.	6,418	$47K	0.0%	+29.6%	0.011%
11/10/2021	Alliancebernstein L.P.	35,800	$0.26M	0.0%	-6.5%	0.061%
11/9/2021	Barclays PLC	20,611	$0.15M	0.0%	-21.6%	0.035%
11/9/2021	BlackRock Inc.	2,215,655	$16.13M	0.0%	+4.2%	3.783%
11/9/2021	Principal Financial Group Inc.	482,401	$3.51M	0.0%	+1.6%	0.824%
11/5/2021	TRV GP IV LLC	6,758,204	$49.20M	11.2%	-15.6%	11.539%
11/5/2021	Truist Financial Corp	125,820	$0.92M	0.0%	+6.2%	0.215%
11/3/2021	Dupont Capital Management Corp	38,529	$0.28M	0.0%	+46.9%	0.066%
11/2/2021	New York State Common Retirement Fund	14,971	$0.11M	0.0%	-41.8%	0.026%
11/1/2021	SG Americas Securities LLC	14,639	$0.11M	0.0%	N/A	0.025%
10/29/2021	Vontobel Holding Ltd.	14,790	$0.11M	0.0%	N/A	0.025%
10/25/2021	Cerity Partners LLC	20,000	$0.15M	0.0%	-23.1%	0.034%
10/18/2021	Nisa Investment Advisors LLC	15,395	$0.11M	0.0%	N/A	0.026%
8/17/2021	Price T Rowe Associates Inc. MD	22,558	$0.22M	0.0%	N/A	0.039%
8/17/2021	Citadel Advisors LLC	138,267	$1.35M	0.0%	-82.2%	0.236%

Data available starting January 2016

Magenta Therapeutics, Inc., a biotechnology company focus on improving stem cell transplantation. Its product candidates are designed to bring the curative power of stem cell transplant to patients with blood cancers, genetic diseases, and autoimmune diseases. The company's product portfolio includes MGTA-117, an anti-CD117 antibody conjugated to an amanitin payload that targets hematopoietic stem cells (HSCs) and leukemia cells; and MGTA-45, an anti-human CD45 antibody conjugated to a DNA-interacting payload for HSCs, leukemia cells, and immune cells. In addition, it focus on development of ADC-based conditioning program that targets a receptor of T cells; and novel conditioning and translation stem cell sciences, as well as develops cell therapy program, E478, which is a small molecule aryl hydrocarbon receptor antagonist for stem cell-based gene therapy and genome editing. In addition, the company has a research and clinical collaboration agreement with AVROBIO, Inc. for the treatment of lysosomal storage disorders; and Beam Therapeutics, Inc. to evaluate the potential utility of MGTA-117 for conditioning of patients with sickle cell disease and beta-thalassemia. Magenta Therapeutics, Inc. was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $0.70

$0.68

$0.76

50 Day Range

MA: $0.53

$0.36

$0.76

52 Week Range

Now: $0.70

$0.32

$2.07

Volume

376,000 shs

Average Volume

848,835 shs

Market Capitalization

$42.44 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.12